F.D.A.
ORG
F.D.A.
The scientists at the Food and Drug Administration repeatedly and unanimously recommended rejecting the application of its maker, Cyberonics Inc., to sell it as such a treatment, said the report, written by the staff of the Senate Finance Committee. That approval did follow the backing of a divided F.D.A. advisory committee.